This study demonstrated that the upregulation of THSD7A may drive immunosuppression, inflammatory responses, and activation of EMT signaling pathways via the aforementioned ligand-receptor pairs, resulting in gastric cancer progression. The gene discussed is THSD7A; the disease is gastric cancer.